biotech / news / / Siliconrepublic.com
The investment will strengthen Galway’s position as a global centre for cardiovascular innovation.
Boston Scientific is investing €75m to expand R&D capabilities in Galway.
KEY POINTS
- The investment includes purpose-built laboratories focused on cardiovascular therapies such as heart failure and renal denervation.
- This expansion leverages Galway's regional STEM talent and ecosystem to develop next-generation medical technologies.
- Galway's medtech reputation is strengthened by Boston Scientific's continued commitment, supported by the Irish government and IDA Ireland.
COMPANIES
Summarized by Newsio from Siliconrepublic.com. How we summarize →